Literature DB >> 17081092

Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential.

Jonathan D Smith1, Eric J Topol.   

Abstract

Atherosclerosis is a common, complex trait, with genetic variation in many genes and the environment contributing to risk for this condition, which has multiple and highly variable phenotypic manifestations. Progress has been made in the identification of atherosclerosis-modifying genes in both human studies and through the use of animal models. In the future, it may be possible to administer a genetic test for variation in a handful of the most common atherosclerosis-modifier genes, and thus predict if a patient is likely to develop atherosclerosis and ischemic heart disease. These patients could then be treated aggressively to lower their low-density lipoprotein cholesterol levels and other risk factors, including counseling to make adjustments in their lifestyle. This review will summarize the methods and results thus far in the identification of atherosclerosis-modifier genes.

Entities:  

Mesh:

Year:  2006        PMID: 17081092     DOI: 10.1586/14779072.4.5.703

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  2 in total

1.  No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice.

Authors:  Daniel Teupser; Odile Weber; Tata Nageswara Rao; Kristina Sass; Joachim Thiery; Hans Jörg Fehling
Journal:  J Biol Chem       Date:  2010-12-11       Impact factor: 5.157

2.  Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.

Authors:  Sandra Mastroianno; Giuseppe Di Stolfo; Davide Seripa; Michele Antonio Pacilli; Giulia Paroni; Carlo Coli; Maria Urbano; Carmela d'Arienzo; Carolina Gravina; Domenico Rosario Potenza; Giovanni De Luca; Antonio Greco; Aldo Russo
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.